In this study, animals that responded to CTLA-4 therapy showed a homogeneous distribution of the anti-CD8+ PET signal throughout the tumor, whereas more heterogeneous infiltration of CD8+ T cells correlated with faster tumor growth and worse response. This evidence concerns the gene CD8A and neoplasm.